financetom
Business
financetom
/
Business
/
BRIEF-Morgan Stanley Reports Passive Stake Of 7.7% In Fastly Inc As Of September 30, 2024
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Morgan Stanley Reports Passive Stake Of 7.7% In Fastly Inc As Of September 30, 2024
Nov 9, 2024 11:29 AM

Nov 6 (Reuters) - Morgan Stanley ( MS ):

* MORGAN STANLEY REPORTS PASSIVE STAKE OF 7.7% IN FASTLY INC

AS OF

SEPTEMBER 30, 2024 - SEC FILING

Source text:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Why Avenue Therapeutics (ATXI) Shares Are Getting Hammered
Why Avenue Therapeutics (ATXI) Shares Are Getting Hammered
Apr 24, 2024
Avenue Therapeutics Inc ( ATXI ) shares are trading lower by 28.5% to $0.09 during Wednesday’s session after the company announced a reverse stock split. The company is implementing a 1-for-75 reverse stock split of its common stock, effective April 26. This decision, approved by the company’s Board of Directors and a majority of stockholders, aims to meet Nasdaq’s requirement...
Moderna to Collaborate With OpenAI to Launch New Generation of Medicines
Moderna to Collaborate With OpenAI to Launch New Generation of Medicines
Apr 24, 2024
11:36 AM EDT, 04/24/2024 (MT Newswires) -- Moderna ( MRNA ) and OpenAI said Wednesday they will continue to collaborate to launch a new generation of medicines. The drugmaker and Microsoft ( MSFT )-backed (MSFT) OpenAI started their collaboration in early 2023 with the launch of Moderna's ( MRNA ) own instance of ChatGPT, called mChat. Moderna ( MRNA )...
Caltech resolves lawsuit against HP over Wi-Fi patents
Caltech resolves lawsuit against HP over Wi-Fi patents
Apr 24, 2024
April 24 (Reuters) - The California Institute of Technology has agreed to drop its lawsuit accusing HP Inc ( HPQ ) of infringing patents related to wireless communications, according to a filing in Texas federal court. Caltech and HP told the U.S. District Court for the Western District of Texas on Tuesday that they would dismiss the case with prejudice,...
Ascendis Pharma Gets UK Regulator's Approval for Yorvipath to Treat Hypoparathyroidism
Ascendis Pharma Gets UK Regulator's Approval for Yorvipath to Treat Hypoparathyroidism
Apr 24, 2024
11:33 AM EDT, 04/24/2024 (MT Newswires) -- Ascendis Pharma ( ASND ) said Wednesday that the UK's Medicines and Healthcare Products Regulatory Agency has granted marketing authorization for Yorvipath as a parathyroid hormone, or PTH, replacement therapy to treat adults with chronic hypoparathyroidism. The UK regulator also granted orphan drug status to Yorvipath, or palopegteriparatide, providing 10 years of market...
Copyright 2023-2026 - www.financetom.com All Rights Reserved